Specific inhibition of PI3Kδ/γ enhances the efficacy of anti-PD1 against osteosarcoma cancer

Impressive responses have been observed in patients with cancer treated with checkpoint inhibitory anti-programmed cell death-1 (PD-1) or anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibodies through disinhibiting the immune system. However, tumors possess complex immunosuppressive tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xinge, Li, Xiqing, Wang, Hongqiang, Yu, Zhenghong, Zhu, Yu, Gao, Yanzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617297/
https://www.ncbi.nlm.nih.gov/pubmed/31334002
http://dx.doi.org/10.1016/j.jbo.2018.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617297/
https://www.ncbi.nlm.nih.gov/pubmed/31334002
http://dx.doi.org/10.1016/j.jbo.2018.11.001

Ejemplares similares